ADAMTS18 and nonpapillary renal cell carcinoma: Some researchers have argued that the ADAMTS18 methylation percentage in primary ccRCC primary tumors (43.6%) is not likely to be high enough to warrant the use of this gene as an effective marker, and the hypomethylation data were not convincing.